First Patient Treated In Neuralstem Phase I Spinal Cord Injury Stem Cell Trial … – CNNMoney
|
First Patient Treated In Neuralstem Phase I Spinal Cord Injury Stem Cell Trial …
CNNMoney GERMANTOWN, Md., Oct. 9, 2014 /PRNewswire/ — Neuralstem, Inc. (NYSE MKT: CUR) announced that the first patient was treated last week in the Phase I trial testing NSI-566 human neural stem cells in the treatment of chronic spinal cord injury (cSCI) at … First spinal cord patient treated in stem cell trial at UCSD UC San Diego releases 1st Neuralstem patient |
